AwardTape · Defense awards · Medical · Diagnostics and lab supplies · SPE8EQ23D0004
SPE8EQ23D0004: $0 IDIQ contract to Alfresa Corporation
Alfresa Corporation holds an IDIQ contract from Defense Logistics Agency with $0 obligated since Oct 2023, against a ceiling of $474K. Latest action May 7, 2024.
4610103894 medicalxreagentxpac
| PIID | SPE8EQ23D0004 |
|---|---|
| Type | IDIQ contract |
| Company | Alfresa Corporation |
| Agency | Defense Logistics Agency |
| Contracting office | DLA TROOP SUPPORT INDO-PACIFIC |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $0 |
| Ceiling (base and all options) | $474K |
| Base date | Jul 24, 2023 |
| Latest action | May 7, 2024 |
| End date | n/a |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Full and open competition |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial